Caffeic Acid Phenylethyl Ester and MG-132 Have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells

Overview

Journal Transl Oncol

Specialty Oncology

Date 2009 Mar 3

PMID 19252751

Citations 7

Authors

Victoria Cavaliere

Daniela L Papademetrio

Mario Lorenzetti

Pamela Valva

Maria Victoria Preciado

Patricia Gargallo

Irene Larripa

Mariela B Monreal

Maria Laura Pardo

Silvia E Hajos

Guillermo Ac Blanco

Elida Mc Alvarez

Affiliations

Soon will be listed here.

Abstract

Chemotherapy aims to limit proliferation and induce apoptotic cell death in tumor cells. Owing to blockade of signaling pathways involved in cell survival and proliferation, nuclear factor kappaB (NF-kappaB) inhibitors can induce apoptosis in a number of hematological malignancies. The efficacy of conventional chemotherapeutic drugs, such as vincristine (VCR) and doxorubicine (DOX), may be enhanced with combined therapy based on NF-kappaB modulation. In this study, we evaluated the effect of caffeic acid phenylethyl ester (CAPE) and MG-132, two nonspecific NF-kappaB inhibitors, and conventional chemotherapeutics drugs DOX and VCR on cell proliferation and apoptosis induction on a lymphoblastoid B-cell line, PL104, established and characterized in our laboratory. CAPE and MG-132 treatment showed a strong antiproliferative effect accompanied by clear cell cycle deregulation and apoptosis induction. Doxorubicine and VCR showed antiproliferative effects similar to those of CAPE and MG-132, although the latter drugs showed an apoptotic rate two-fold higher than DOX and VCR. None of the four compounds showed cytotoxic effect on peripheral mononuclear cells from healthy volunteers. CAPE- and MG-132-treated bone marrow cells from patients with myeloid and lymphoid leukemias showed 69% (P < .001) and 25% decrease (P < .01) in cell proliferation and 42% and 34% (P < .01) apoptosis induction, respectively. Overall, our results indicate that CAPE and MG-132 had a strong and selective apoptotic effect on tumor cells that may be useful in future treatment of hematological neoplasias.

Citing Articles

Tumor integrin targeted theranostic iron oxide nanoparticles for delivery of caffeic acid phenethyl ester: preparation, characterization, and anti-myeloma activities.

Smith B, Li Y, Fields T, Tucker M, Staskiewicz A, Wong E Front Pharmacol. 2024; 15:1325196.

PMID: 38510655 PMC: 10952826. DOI: 10.3389/fphar.2024.1325196.

Recent progresses in the pharmacological activities of caffeic acid phenethyl ester.

Lv L, Cui H, Ma Z, Liu X, Yang L Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(7):1327-1339.

PMID: 33492405 DOI: 10.1007/s00210-021-02054-w.

Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines.

Lompardia S, Diaz M, Pibuel M, Papademetrio D, Poodts D, Mihalez C Sci Rep. 2019; 9(1):10930.

PMID: 31358779 PMC: 6662747. DOI: 10.1038/s41598-019-47248-8.

4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines.

Lompardia S, Diaz M, Papademetrio D, Pibuel M, Alvarez E, Hajos S Invest New Drugs. 2016; 35(1):1-10.

PMID: 27718039 DOI: 10.1007/s10637-016-0397-9.

Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.

Papademetrio D, Lompardia S, Simunovich T, Costantino S, Mihalez C, Cavaliere V Target Oncol. 2015; 11(2):183-95.

PMID: 26373299 DOI: 10.1007/s11523-015-0388-3.

References

San-Miguel J, Richardson P, Sonneveld P, Schuster M, Irwin D, Stadtmauer E . Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study. Leukemia. 2008; 22(4):842-9. DOI: 10.1038/sj.leu.2405087. View

Skladanowski A, Come M, Sabisz M, Escargueil A, Larsen A . Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents. Mol Pharmacol. 2005; 68(3):625-34. DOI: 10.1124/mol.105.013995. View

Keller S, Schattner E, Cesarman E . Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood. 2000; 96(7):2537-42. View

Cilloni D, Messa F, Arruga F, Defilippi I, Morotti A, Messa E . The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance. Leukemia. 2005; 20(1):61-7. DOI: 10.1038/sj.leu.2403998. View

Celec P . Nuclear factor kappa B--molecular biomedicine: the next generation. Biomed Pharmacother. 2004; 58(6-7):365-71. DOI: 10.1016/j.biopha.2003.12.015. View

Wu M, Lee H, Bellas R, Schauer S, Arsura M, Katz D . Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 1996; 15(17):4682-90. PMC: 452200. View

Munshi A, Kurland J, Nishikawa T, Chiao P, Andreeff M, Meyn R . Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells. Mol Cancer Ther. 2004; 3(8):985-92. View

Orsolic N, Sver L, Terzic S, Tadic Z, Basic I . Inhibitory effect of water-soluble derivative of propolis and its polyphenolic compounds on tumor growth and metastasizing ability: a possible mode of antitumor action. Nutr Cancer. 2004; 47(2):156-63. DOI: 10.1207/s15327914nc4702_8. View

Beg A, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 1996; 274(5288):782-4. DOI: 10.1126/science.274.5288.782. View

10.

Naujokat C, Sezer O, Zinke H, Leclere A, Hauptmann S, Possinger K . Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells. Eur J Haematol. 2000; 65(4):221-36. DOI: 10.1034/j.1600-0609.2000.065004221.x. View

11.

Watabe M, Hishikawa K, Takayanagi A, Shimizu N, Nakaki T . Caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells. J Biol Chem. 2003; 279(7):6017-26. DOI: 10.1074/jbc.M306040200. View

12.

Dalton W . The tumor microenvironment: focus on myeloma. Cancer Treat Rev. 2003; 29 Suppl 1:11-9. DOI: 10.1016/s0305-7372(03)00077-x. View

13.

Alaniz L, Garcia M, Cabrera P, Arnaiz M, Cavaliere V, Blanco G . Modulation of matrix metalloproteinase-9 activity by hyaluronan is dependent on NF-kappaB activity in lymphoma cell lines with dissimilar invasive behavior. Biochem Biophys Res Commun. 2004; 324(2):736-43. DOI: 10.1016/j.bbrc.2004.09.120. View

14.

Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M . Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene. 2004; 23(34):5843-52. DOI: 10.1038/sj.onc.1207757. View

15.

Lin Y, Chiu J, Tseng W, Wong T, Chiou S, Yen S . Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells. Cancer Chemother Pharmacol. 2005; 57(4):525-32. DOI: 10.1007/s00280-005-0066-8. View

16.

Guo J, Verma U, Gaynor R, Frenkel E, Becerra C . Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit. Clin Cancer Res. 2004; 10(10):3333-41. DOI: 10.1158/1078-0432.CCR-03-0366. View

17.

Witkowski J, Zmuda-Trzebiatowska E, Swiercz J, Cichorek M, Ciepluch H, Lewandowski K . Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood. 2002; 100(5):1802-9. DOI: 10.1182/blood-2001-11-0073. View

18.

Adams J . The development of proteasome inhibitors as anticancer drugs. Cancer Cell. 2004; 5(5):417-21. DOI: 10.1016/s1535-6108(04)00120-5. View

19.

Garcia M, Alaniz L, Lopes E, Blanco G, Hajos S, Alvarez E . Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines. Leuk Res. 2005; 29(12):1425-34. DOI: 10.1016/j.leukres.2005.05.004. View

20.

Li X, Gong J, Feldman E, Seiter K, Traganos F, Darzynkiewicz Z . Apoptotic cell death during treatment of leukemias. Leuk Lymphoma. 1994; 13 Suppl 1:65-70. DOI: 10.3109/10428199409052678. View